Andere Sprachen

08.08.25 2invest AG Reports Earnings Results for the Half Year Ended June 30, 2025
16.06.25 2invest AG's Equity Buyback announced on June 17, 2020, has expired.
28.02.25 Leucid Bio Ltd announced that it has received £7.2 million in funding from Epidarex Capital, 2invest AG
27.02.25 2invest AG Reports Earnings Results for the Full Year Ended December 31, 2024
05.08.24 2invest AG Reports Earnings Results for the Half Year Ended June 30, 2024
29.07.24 Elevage Medical Technologies and M&G Investment Management Limited signed term sheet to acquire an 15% stake in 4basebio PLC from entities belonging to Deutsche Balaton AG, certain management and directors of 4basebio and 2invest AG for £29.39 million.
24.04.24 2invest AG Reports Earnings Results for the Full Year Ended December 31, 2023
27.03.24 Geopacific Resources Extends Maturity Date of Bearer Bonds
02.01.24 Geopacific Resources Secures Further AU$1.8 Million Funding for Woodlark Gold Project; Shares Down 5%
17.08.23 2invest AG Reports Earnings Results for the Half Year Ended June 30, 2023
06.04.23 2invest AG Reports Earnings Results for the Full Year Ended December 31, 2022
07.09.22 Theta Gold Mines Limited (ASX:TGM) Issue of New Call Options to 2Invest AG
11.08.22 2invest AG Reports Earnings Results for the Half Year Ended June 30, 2022
08.08.22 2invest : Pre-announcement of a financial report according to articles 114 – 117 WpHG
25.05.22 2invest : Release according to Article 40, Section 1 of the WpHG
19.05.22 2invest : Release according to Article 40, Section 1 of the WpHG
13.05.22 Theta Gold Mines Limited (ASX:TGM) Option to Extend Secure Bond Maturity Date
20.04.22 2invest AG Reports Earnings Results for the Full Year Ended December 31, 2021
14.04.22 2invest : Pre-announcement of a financial report according to articles 114 – 117 WpHG
23.03.22 Heqet Therapeutics S.R.L. announced that it has received £6.6 million in funding from Claris Ventures SGR SpA, 2invest AG
16.03.22 Kither Biotech s.r.l. announced that it has received €18.5 million in funding from a group of investors
25.02.22 2invest : Preliminary annual results as of 31 December 2021
29.11.21 2invest : Change of forecast for the financial year 2021
05.11.21 Revocation of the admission to the Prime Standard
21.10.21 Leucid Bio Ltd announced that it has received ?11.5 million in funding from Epidarex Capital, Vulpes Investment Management Private Ltd, 2invest AG, British Business Investments Ltd., Sofinnova Partners SAS
Keine Ergebnisse zu dieser Suche